Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis

Sponsor
Indiana Kidney Stone Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT00169806
Collaborator
Indiana University School of Medicine (Other), University of Chicago (Other)
600
1
1
325
1.8

Study Details

Study Description

Brief Summary

Kidney stones are very common. They affect 3-5% of the population in the United States. Many people are hospitalized for the treatment of kidney stones and some may die. Better understanding of what causes kidney stones is useful in both the treatment and prevention of kidney stones. However, exactly what causes kidney stones is unknown.

The most common type of kidney stones contains calcium, which sometimes is attached to a part of the kidney important in producing the final urine, called the papilla. The investigators have noticed that persons who form kidney stones seem to have more papilla with stones attached. They propose to study these areas of the papilla, called Randall's plaques (named after their discoverer), in patients undergoing surgery for kidney stones.

Condition or Disease Intervention/Treatment Phase
  • Other: videotape for mapping of renal anatomy and papillary biopsy
N/A

Detailed Description

In order to attempt to explain the pathogenesis of renal calculi, the investigators videotape and document the location and characteristics of each stone, papillae and calyces. One or more small papillary biopsies are taken for analysis to help determine the point of origin of the kidney stone and histological studies are undertaken to determine tissue differences amongst different types of stone formers. Approximately one month after surgery, metabolic studies are undertaken to further review potential causes of stone formation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Randall's Plaques: Pathogenesis and Relationship to Nephrolithiasis
Study Start Date :
Nov 1, 1998
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: cohort

Subjects who are scheduled to undergo a percutaneous kidney stone removal who do not have complicated comorbidities

Other: videotape for mapping of renal anatomy and papillary biopsy
Subjects who enroll in this study will have their renal anatomy videotaped for mapping purposes. Stone location and characteristics will be documented as will papilla and calyces. One or more papillary biopsies will be taken for analysis.

Outcome Measures

Primary Outcome Measures

  1. To find out why people form stones by comparing 24 urine collections, biopsy and anatomy to other patients who do not form stones and other patients who do form stones to see if the differences are significant [One year from study completion]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of Methodist Urology in Indianapolis, IN who are undergoing endoscopic procedures for nephrolithiasis or other urologic disease.

  • Upper urinary tract endoscopic or PERC procedure for kidney stones removal

  • General medical health allowing surgical procedure

  • Ability to complete all the necessary components of the study

  • Able to sign an informed consent

Exclusion Criteria:
  • Poor general medical health

  • Bleeding diathesis

  • Inability or unwillingness to comply with post-surgical follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 IU Health Methodist Hospital Indianapolis Indiana United States 46202

Sponsors and Collaborators

  • Indiana Kidney Stone Institute
  • Indiana University School of Medicine
  • University of Chicago

Investigators

  • Principal Investigator: James Lingeman, MD, IU Health Physicians Urology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
James Lingeman, James Lingeman, MD, Indiana Kidney Stone Institute
ClinicalTrials.gov Identifier:
NCT00169806
Other Study ID Numbers:
  • 98-073
First Posted:
Sep 15, 2005
Last Update Posted:
Jan 20, 2022
Last Verified:
Jan 1, 2022
Keywords provided by James Lingeman, James Lingeman, MD, Indiana Kidney Stone Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 20, 2022